Despite the need for non-opioid alternatives, breaking into the pain market is not an easy task.
By contrast, countries like India, which do not award patent term extensions, could see generic competition entering much sooner once the patents on the main compound expire there in 2026
This includes Sjgren syndrome, Crohns disease, celiac disease, and some autoimmune diseases
Read More A 503B outsourcing facility is a type of drug manufacturing establishment authorized to compound medications in bulk, with or without patient-specific prescriptions, for distribution to healthcare facilities for office or office-administered use
Using tools like a compounded Semaglutide dosage chart in partnership with expert guidance helps set you up for long-term success